Prognostic impact of a past or synchronous second cancer in diffuse large B cell lymphoma

Blood Cancer J. 2018 Jan 25;8(1):1. doi: 10.1038/s41408-017-0043-6.

Kazuna Tanba^{1

2}, Yoshiaki Chinen^{3

4}, Hitoji Uchiyama^{2

5}, Nobuhiko Uoshima^{2

6}, Kazuho Shimura^{2

7}, Shinichi Fuchida^{2

8}, Miki Kiyota^{2

9}, Mitsushige Nakao^{2

10}, Yuji Shimura^{1

2}, Tsutomu Kobayashi^{1

2}, Shigeo Horiike^{1

2}, Katsuya Wada^{2

9}, Chihiro Shimazaki^{2

8}, Hiroto Kaneko^{2

7}, Yutaka Kobayashi^{2

6}, Masafumi Taniwaki^{2

7}, Junya Kuroda^{1

2}

¹ Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan.
² Kyoto Clinical Hematology Study Group, Kyoto, Japan.
³ Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan. y-chinen@koto.kpu-m.ac.jp.
⁴ Kyoto Clinical Hematology Study Group, Kyoto, Japan. y-chinen@koto.kpu-m.ac.jp.
⁵ Department of Hematology, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan.
⁶ Department of Hematology, Japanese Red Cross Kyoto Daini Hospital, Kyoto, Japan.
⁷ Department of Hematology, Aiseikai Yamashina Hospital, Kyoto, Japan.
⁸ Department of Hematology, Japan Community Health Care Organization Kyoto Kuramaguchi Medical Center, Kyoto, Japan.
⁹ Department of Hematology, Matsushita Memorial Hospital, Osaka, Japan.
¹⁰ Department of Internal Medicine, Otsu Municipal Hospital, Shiga, Japan.

No abstract available

Publication types